T Miyata Selected Research

Peripheral Arterial Disease

4/2010	Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
7/2009	Selective and sustained delivery of basic fibroblast growth factor (bFGF) for treatment of peripheral arterial disease: results of a phase I trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Miyata Research Topics

Disease

5	Stroke (Strokes) 08/2009 - 08/2001
5	Atherosclerosis 11/2007 - 03/2000
4	Inflammation (Inflammations) 01/2020 - 07/2001
4	Neoplasms (Cancer) 01/2020 - 11/2001
4	Type 2 Diabetes Mellitus (MODY) 11/2016 - 11/2013
4	Chronic Kidney Failure (Chronic Renal Failure) 09/2014 - 08/2000
4	Abdominal Aortic Aneurysm 03/2012 - 01/2000
4	Ischemia 09/2007 - 06/2001
4	Pathologic Constriction (Stenosis) 12/2006 - 01/2000
4	Venous Thrombosis (Deep-Vein Thrombosis) 09/2006 - 04/2000
4	Uremia 01/2002 - 08/2000
3	Hypoxia (Hypoxemia) 01/2017 - 06/2000
3	Insulin Resistance 10/2015 - 07/2000
3	Infections 09/2014 - 08/2000
3	Thrombotic Thrombocytopenic Purpura 07/2013 - 07/2011
3	Vascular Diseases (Vascular Disease) 01/2012 - 07/2001
3	Proteinuria 12/2007 - 05/2000
3	Protein C Deficiency 08/2001 - 01/2000
2	Thrombosis (Thrombus) 01/2017 - 07/2007
2	Aneurysm (Aneurysms) 10/2014 - 01/2000
2	Necrosis 09/2014 - 04/2004
2	Diabetes Mellitus 11/2013 - 12/2001
2	Atherosclerotic Plaque (Atheroma) 03/2012 - 07/2001
2	Thromboangiitis Obliterans (Buerger's Disease) 04/2011 - 10/2000
2	Renal Insufficiency (Renal Failure) 11/2010 - 10/2000
2	Essential Hypertension 05/2010 - 11/2007
2	Hemorrhage 04/2010 - 06/2001
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2010 - 07/2003
2	Peripheral Arterial Disease 04/2010 - 07/2009
2	Obesity 12/2007 - 07/2000
2	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2001 - 01/2001
2	Leukemia 09/2001 - 03/2000
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2001 - 01/2000
2	Cerebral Infarction 08/2001 - 01/2000
2	Amyloidosis 01/2001 - 08/2000
2	Bile Duct Neoplasms (Bile Duct Cancer) 04/2000 - 04/2000
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 04/2000 - 01/2000
1	Ischemic Stroke 01/2022
1	HIV Infections (HIV Infection) 01/2021
1	Heart Failure 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Body Weight (Weight, Body) 11/2016

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 09/2006 - 04/2000
5	LipidsIBA 01/2016 - 05/2000
5	Protein CIBA 09/2006 - 01/2000
4	Advanced Glycation End ProductsIBA 12/2001 - 10/2000
3	Blood Glucose (Blood Sugar)IBA 11/2016 - 11/2013
3	thiamine triphosphorate (TTP)IBA 07/2013 - 07/2011
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2009 - 06/2001
2	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2015
2	Hemoglobins (Hemoglobin)IBA 11/2016 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 07/2000
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016 - 10/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2014 - 09/2000
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 11/2013 - 06/2000
2	MicellesIBA 01/2012 - 07/2007
2	Contrast MediaIBA 10/2011 - 11/2010
2	Insulin (Novolin)FDA Link 05/2010 - 12/2007
2	AnticoagulantsIBA 03/2010 - 09/2006
2	Hyaluronic Acid (Hyaluronan)IBA 06/2007 - 08/2003
2	PlasminogenIBA 11/2003 - 04/2000
2	CarbohydratesIBA 01/2002 - 08/2000
2	CreatinineIBA 11/2001 - 05/2000
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2000 - 04/2000
2	4- diethoxyphosphorylmethyl- N- (4- bromo- 2- cyanophenyl)benzamideIBA 07/2000 - 05/2000
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 07/2000 - 05/2000
2	HomocysteineIBA 06/2000 - 04/2000
1	AlbuminsIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	BucladesineIBA 01/2017
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2017
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2017
1	mirdametinibIBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2016
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 11/2016
1	SodiumIBA 11/2016
1	Guanosine Triphosphate (GTP)IBA 11/2016
1	Alanine Transaminase (SGPT)IBA 11/2016
1	SymportersIBA 11/2016
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 11/2016
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2016

Therapy/Procedure

6	Therapeutics 01/2022 - 03/2000
4	Endovascular Aneurysm Repair 03/2012 - 01/2000
4	Carotid Endarterectomy 09/2007 - 12/2004
4	Stents 12/2006 - 01/2000
3	Renal Dialysis (Hemodialysis) 01/2021 - 07/2001
3	Glycemic Control 01/2016 - 12/2007
3	Limb Salvage 09/2014 - 01/2003
2	Surgical Amputation (Amputations) 01/2021 - 09/2014
2	Blood Transfusion (Blood Transfusions) 01/2019 - 07/2011
2	Catheters 08/2000 - 01/2000
1	Thrombectomy 01/2022
1	Liver Transplantation 01/2021
1	Endurance Training 01/2017
1	Intravenous Administration 01/2017
1	Lasers (Laser) 01/2017